Cargando…
CD24: A Novel Target for Cancer Immunotherapy
Cluster of differentiation 24 (CD24) is a small, highly glycosylated cell adhesion protein that is normally expressed by immune as well as epithelial, neural, and muscle cells. Tumor CD24 expression has been linked with alterations in several oncogenic signaling pathways. In addition, the CD24/Sigle...
Autores principales: | Panagiotou, Emmanouil, Syrigos, Nikolaos K., Charpidou, Andriani, Kotteas, Elias, Vathiotis, Ioannis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409925/ https://www.ncbi.nlm.nih.gov/pubmed/36013184 http://dx.doi.org/10.3390/jpm12081235 |
Ejemplares similares
-
HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
por: Vathiotis, Ioannis A., et al.
Publicado: (2021) -
Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases
por: Trontzas, Ioannis P., et al.
Publicado: (2023) -
Tumor Dormancy: Implications for Invasion and Metastasis
por: Gomatou, Georgia, et al.
Publicado: (2021) -
Malignant Superior Vena Cava Syndrome: State of the Art
por: Patriarcheas, Vasileios, et al.
Publicado: (2022) -
Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)